Quantcast
Channel: DR ANTHONY MELVIN CRASTO Ph.D – All About Drugs
Viewing all articles
Browse latest Browse all 823

European Commission approves Fluenz Tetra for the prevention of seasonal influenza in children

$
0
0

Friday, 6 December 2013

AstraZeneca today announced that the European Commission (EC) has granted Marketing Authorisation to FluenzTM Tetra. Fluenz Tetra is a nasally administered four-strain live attenuated influenza vaccine for the prevention of influenza in children and adolescents from 24 months up to 18 years of age. The EC approval makes Fluenz Tetra the first and only intra-nasal four-strain influenza vaccine available in Europe.http://www.pharmalive.com/ec-approves-fluenz-tetra

 

 

Share


Viewing all articles
Browse latest Browse all 823

Trending Articles